Zimmer Biomet Holdings Research and Development Expenses 2012-2026 | ZBH
Zimmer Biomet Holdings annual/quarterly research and development expenses history and growth rate from 2012 to 2026. Research and development expenses can be defined as an expense arising from studies and product development processes.
- Zimmer Biomet Holdings research and development expenses for the quarter ending June 30, 2026 were $0.105B, a 7.5% decline year-over-year.
- Zimmer Biomet Holdings research and development expenses for the twelve months ending June 30, 2026 were $0.443B, a 0.27% decline year-over-year.
- Zimmer Biomet Holdings annual research and development expenses for 2025 were $0.459B, a 4.82% increase from 2024.
- Zimmer Biomet Holdings annual research and development expenses for 2024 were $0.437B, a 4.64% decline from 2023.
- Zimmer Biomet Holdings annual research and development expenses for 2023 were $0.459B, a 12.98% increase from 2022.
|
Zimmer Biomet Holdings Annual Research and Development Expenses (Millions of US $) |
|
|---|---|
| 2025 | $459 |
| 2024 | $437 |
| 2023 | $459 |
| 2022 | $406 |
| 2021 | $436 |
| 2020 | $323 |
| 2019 | $449 |
| 2018 | $392 |
| 2017 | $370 |
| 2016 | $366 |
| 2015 | $269 |
| 2014 | $187 |
| 2013 | $203 |
| 2012 | $226 |
| 2011 | $238 |
|
Zimmer Biomet Holdings Quarterly Research and Development Expenses (Millions of US $) |
|
|---|---|
| 2026-06-30 | $105 |
| 2026-03-31 | $103 |
| 2025-12-31 | $119 |
| 2025-09-30 | $116 |
| 2025-06-30 | $113 |
| 2025-03-31 | $111 |
| 2024-12-31 | $109 |
| 2024-09-30 | $112 |
| 2024-06-30 | $109 |
| 2024-03-31 | $108 |
| 2023-12-31 | $113 |
| 2023-09-30 | $117 |
| 2023-06-30 | $118 |
| 2023-03-31 | $110 |
| 2022-12-31 | $108 |
| 2022-09-30 | $102 |
| 2022-06-30 | $99 |
| 2022-03-31 | $97 |
| 2021-12-31 | $96 |
| 2021-09-30 | $94 |
| 2021-06-30 | $165 |
| 2021-03-31 | $81 |
| 2020-12-31 | $51 |
| 2020-09-30 | $86 |
| 2020-06-30 | $88 |
| 2020-03-31 | $98 |
| 2019-12-31 | $121 |
| 2019-09-30 | $114 |
| 2019-06-30 | $112 |
| 2019-03-31 | $102 |
| 2018-12-31 | $101 |
| 2018-09-30 | $96 |
| 2018-06-30 | $99 |
| 2018-03-31 | $96 |
| 2017-12-31 | $95 |
| 2017-09-30 | $91 |
| 2017-06-30 | $93 |
| 2017-03-31 | $91 |
| 2016-12-31 | $96 |
| 2016-09-30 | $96 |
| 2016-06-30 | $89 |
| 2016-03-31 | $86 |
| 2015-12-31 | $86 |
| 2015-09-30 | $83 |
| 2015-06-30 | $51 |
| 2015-03-31 | $48 |
| 2014-12-31 | $46 |
| 2014-09-30 | $46 |
| 2014-06-30 | $48 |
| 2014-03-31 | $47 |
| 2013-12-31 | $45 |
| 2013-09-30 | $49 |
| 2013-06-30 | $55 |
| 2013-03-31 | $54 |
| 2012-12-31 | $55 |
| 2012-09-30 | $54 |
| 2012-06-30 | $57 |
| 2012-03-31 | $60 |
| 2011-12-31 | $65 |
| 2011-09-30 | $61 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $18.189B | $8.232B |
| Zimmer Biomet is a leading musculoskeletal healthcare company that designs, manufactures and markets orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; spine, bone healing, craniomaxillofacial and thoracic products; dental implants; and related surgical products. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $177.555B | 19.51 |
| Medtronic (MDT) | Ireland | $117.847B | 16.11 |
| Stryker (SYK) | United States | $105.529B | 19.72 |
| EssilorLuxottica (ESLOY) | France | $73.880B | 0.00 |
| Boston Scientific (BSX) | United States | $62.810B | 13.50 |
| Lonza Group Ag (LZAGY) | Switzerland | $46.597B | 0.00 |
| Agilent Technologies (A) | United States | $44.113B | 25.82 |
| Medline (MDLN) | United States | $41.597B | 0.00 |
| ResMed (RMD) | United States | $32.455B | 20.14 |
| GE HealthCare Technologies (GEHC) | United States | $28.967B | 13.85 |
| Koninklijke Philips (PHG) | Netherlands | $24.258B | 12.92 |
| Terumo (TRUMY) | Japan | $20.887B | 19.94 |
| Baxter (BAX) | United States | $11.788B | 11.12 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $11.573B | 0.00 |
| Demant (WILYY) | Denmark | $10.101B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $10.065B | 40.56 |
| Insulet (PODD) | United States | $9.751B | 23.95 |
| Sunny Optical Technology (SNPTF) | China | $9.508B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $6.563B | 20.19 |
| Raia Drogasil SA - (RADLY) | Brazil | $5.024B | 0.00 |
| BillionToOne (BLLN) | United States | $4.998B | 151.31 |
| Haemonetics (HAE) | United States | $4.932B | 21.64 |
| DiaSorin S.p.A (DSRLF) | Italy | $4.705B | 0.00 |
| ICU Medical (ICUI) | United States | $3.815B | 22.78 |
| Envista Holdings (NVST) | United States | $3.750B | 15.88 |
| AtriCure (ATRC) | United States | $2.955B | 252.61 |
| Neogen (NEOG) | United States | $2.835B | 50.00 |
| Curaleaf Holdings (CURLF) | United States | $2.445B | 0.00 |
| Curaleaf Holdings (CURLD) | Canada | $2.388B | 0.00 |
| GN Store Nord (GNNDY) | Denmark | $2.265B | 0.00 |
| Trulieve Cannabis (TRLV) | United States | $2.132B | 0.00 |
| Prestige Consumer Healthcare (PBH) | United States | $2.130B | 10.17 |
| Perrigo (PRGO) | Ireland | $1.882B | 5.42 |
| Maravai LifeSciences Holdings (MRVI) | United States | $1.810B | 0.00 |
| LeMaitre Vascular (LMAT) | United States | $1.804B | 29.00 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $1.798B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.795B | 229.31 |
| Kestra Medical Technologies (KMTS) | United States | $1.455B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.426B | 15.21 |
| Phibro Animal Health (PAHC) | United States | $1.403B | 10.77 |
| Omeros (OMER) | United States | $1.294B | 6.55 |
| Lumexa Imaging Holdings (LMRI) | United States | $1.065B | 0.00 |
| CeriBell (CBLL) | United States | $0.935B | 0.00 |
| InMode (INMD) | Israel | $0.825B | 11.48 |
| AdaptHealth (AHCO) | United States | $0.779B | 16.31 |
| VAREX IMAGING (VREX) | United States | $0.778B | 17.12 |
| Glass House Brands (GLAS) | United States | $0.748B | 0.00 |
| QuidelOrtho (QDEL) | United States | $0.728B | 7.87 |
| Valneva SE (VALN) | France | $0.622B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.553B | 0.00 |
| Brainsway (BWAY) | Israel | $0.547B | 30.93 |
| Tilray Brands (TLRY) | Canada | $0.543B | 0.00 |
| Cerus (CERS) | United States | $0.534B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.527B | 0.00 |
| Evolus (EOLS) | United States | $0.519B | 0.00 |
| Vireo Growth (VREOD) | United States | $0.451B | 0.00 |
| Verano Holdings (VRNO) | United States | $0.443B | 0.00 |
| Verano Holdings (VRNOD) | United States | $0.425B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.420B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.395B | 8.28 |
| SNDL (SNDL) | Canada | $0.353B | 0.00 |
| Village Farms (VFF) | Canada | $0.347B | 15.78 |
| Viemed Healthcare (VMD) | United States | $0.339B | 24.75 |
| Sanara MedTech (SMTI) | United States | $0.322B | 159.41 |
| TriSalus Life Sciences (TLSI) | United States | $0.314B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.279B | 0.00 |
| MacroGenics (MGNX) | United States | $0.264B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.251B | 13.35 |
| OraSure Technologies (OSUR) | United States | $0.246B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.235B | 22.55 |
| High Tide (HITI) | Canada | $0.230B | 51.60 |
| Owens & Minor (OMI) | United States | $0.217B | 2.17 |
| Exagen (XGN) | United States | $0.204B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.202B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.197B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.157B | 0.00 |
| Jin Medical (ZJYL) | China | $0.156B | 0.00 |
| Organigram Global (OGI) | Canada | $0.148B | 0.00 |
| Quanterix (QTRX) | United States | $0.145B | 0.00 |
| Apyx Medical (APYX) | United States | $0.129B | 0.00 |
| Fonar (FONR) | United States | $0.115B | 16.53 |
| ImmuCell (ICCC) | United States | $0.090B | 124.38 |
| FitLife Brands (FTLF) | United States | $0.088B | 11.51 |
| Jushi Holdings (JUSHF) | United States | $0.083B | 0.00 |
| Accendra Health (ACH) | United States | $0.068B | 3.87 |
| Sharps Technology (STSS) | United States | $0.065B | 0.00 |
| InterCure (INCR) | Israel | $0.058B | 0.00 |
| Hongchang (HCIL) | China | $0.055B | 0.00 |
| Biote (BTMD) | United States | $0.049B | 4.00 |
| Nephros (NEPH) | United States | $0.047B | 39.18 |
| Veru (VERU) | United States | $0.041B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.039B | 18.96 |
| United-Guardian (UG) | United States | $0.033B | 13.35 |
| Rockwell Medical (RMTI) | United States | $0.033B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.023B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.018B | 0.00 |
| Modular Medical (MODD) | United States | $0.018B | 0.00 |
| Bonk (BNKK) | United States | $0.011B | 0.00 |
| Flora Growth (FLGC) | United States | $0.009B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.008B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.006B | 0.00 |
| Zynex (ZYXI) | United States | $0.004B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.002B | 0.00 |
| Agape ATP (ATPC) | $0.002B | 0.00 | |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.002B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.001B | 0.00 |
| INLIF (INLF) | China | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |